Description
This session will include five submissions considered as high impact science for presentation.
Learning Objectives
- Assess the collateral effects of non target tissue injury.
- Analyze the impact on hemolysis.
- Study the importance of substrate mapping in PFA to avoid iatrogenic arrhythmias.
Session Chair(s)
Atul Verma, MD
T. Jared Bunch, MD
Presentation
Collateral Maladies of Pulse Field Ablation: NEMESIS PFA
Presenter(s): Dhanunjaya R. Lakkireddy, MBA, MD, Aashish Katapadi, MD, Eli Herink, Michael Klotz, Jagruth Ghanta, Jalaj Garg, MD, Rajesh Kabra, MD, Naga Venkata Krishna Chand. Pothineni, MD, Douglas Darden, MD, Rakesh Gopinathannair, MA, MBA, MD, Donita Atkins, BS, BSN, RN, Venkatakrishna N. Tholakanahalli, MD, Sanghamitra Mohanty, MD, MS, Luigi Di Biase, MD, PhD, Andrea Natale, MD
Commentary: Collateral Maladies of Pulse Field Ablation: NEMESIS PFA
Presenter(s): Atul Verma, MD
Prospective Evaluation for Asymptomatic Cerebral Emboli after Pulsed Field Ablation of Atrial Fibrillation (PEACE-AF)
Presenter(s): Christopher C. Cheung, MD, MPH, Maria Terricabras Casas, MD, MS, Sheldon Singh, MD, Sara Jabeen, Rabea Haddad, MD, Chinthaka Heyn, Richard Swartz
Commentary: Prospective Evaluation for Asymptomatic Cerebral Emboli after Pulsed Field Ablation of Atrial Fibrillation (PEACE-AF)
Presenter(s): Luigi Di Biase, MD, PhD
The Role of Post-Ablation Catheter Remapping in Pulsed Field Ablation of Atrial Fibrillation and Related Atrial Arrhythmias
Presenter(s): Aleksandar Izda, Anika Sonig, Alyson Brown, Erin Capodanno, Maria Matteo, Bryan Baranowski, MD, Mandeep Bhargava, MD, Thomas D. Callahan, MD, Koji Higuchi, MD, PhD, Ayman A. Hussein, MD, Mohamed Kanj, MD, Arshneel Singh. Kochar, MD, Robert Koeth, MD, PhD, Justin Z. Lee, MD, David O. Martin, MD, MPH, Shady Nakhla, MD, Walid I. Saliba, MD, Tyler Louis. Taigen, MD, Oussama M. Wazni, MD, Pasquale Santangeli, MD, PhD, Jakub Sroubek, MD, PhD, Mina K. Chung, MD
Commentary: The Role of Post-Ablation Catheter Remapping in Pulsed Field Ablation of Atrial Fibrillation and Related Atrial Arrhythmias
Presenter(s): Rangadham Nagarakanti, MD
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: The Ultra-HFIB pilot study
Presenter(s): Vivek Y. Reddy, MD, William Whang, MD, Devi G. Nair, MD, Rahul Bhardwaj, MD, Marc K. Lahiri, MD, Dinesh Sharma, MD, MPH, Taisei Kobayashi, Shephal K. Doshi, MD, Andrea Natale, MD, Craig B. Moskowitz, MD, Moussa Mansour, MD, Vijendra Swarup, MD, Jeff Lam, Ugur Gurol, Carla Perdomo
Commentary: Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: The Ultra-HFIB pilot study
Presenter(s): Hakan Oral, MD
Acute and long-term clinical outcome after pulsed field ablation in proximity to coronary arteries
Presenter(s): Mark TK Tam, MBChB, Victor CH Chan, CHI KIN AU, MBChB, Li Li Cheung, MD, Chin Pang Chan, MBChB, Joseph YS Chan
Commentary: Acute and long-term clinical outcome after pulsed field ablation in proximity to coronary arteries
Presenter(s): Jacob S. Koruth, MD
Disclosures
Dhanunjaya Lakkireddy:
- Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- AtriCure, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
- Biosense Webster, Inc. (Speakers' Bureau - Speaking and Teaching)
Atul Verma:
- Kardium (Honoraria/Speaking/Consulting Fee - Consulting)
- Servier (Honoraria/Speaking/Consulting Fee - Consulting)
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
- Medtronic (Honoraria/Speaking/Consulting Fee - Membership on Advisory Committees or Review Panels)
- Adagio Medical (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Medlumics (Research (Contracted Grants for PIs and Named Investigators only) - Independent Contractor (including contracted research))
Christopher Cheung:
- Nothing Relevant to Disclose
Luigi Di Biase:
- Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
- Zoll Medical Corporation (Honoraria/Speaking/Consulting Fee - Consulting)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Stereotaxis, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- I-rhythm (Honoraria/Speaking/Consulting Fee - Consulting)
- Baylis Medical Company (Honoraria/Speaking/Consulting Fee - Consulting)
Aleksandar Izda:
- Nothing Relevant to Disclose
Rangadham Nagarakanti:
- Nothing Relevant to Disclose
William Whang:
- Nothing Relevant to Disclose
Hakan Oral:
- Arga (Stock Options – Privately Held (including start-up companies) - Membership on Advisory Committees or Review Panels)
Joseph YS Chan:
- Nothing Relevant to Disclose
Jacob Koruth:
- Kardium (Stock Options – Privately Held (including start-up companies) - Consulting)
- Affera, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
- Field Medical (Stock Options – Privately Held (including start-up companies) - Research)
- Pulse Biosciences (Honoraria/Speaking/Consulting Fee - Research)
- Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- CardioFocus, Inc. (Research (Contracted Grants for PIs and Named Investigators only) - Research)
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here.
Education Framework
Supraventricular Tachyarrhythmias
-- AFib and Flutter - Catheter Ablation
-- 142. Know the indications, contraindications, expected outcomes and complications associated with catheter ablation of atrial fibrillation and flutter, including during pregnancy.